Napoleon Bonaparte's gastric cancer: A clinicopathologic approach to staging, pathogenesis, and etiology

Alessandro Lugli, Inti Zlobec, Gad Singer, Andrea Kopp Lugli, Luigi M. Terracciano, Robert M. Genta

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: Numerous hypotheses on the cause of Napoleon Bonaparte's death have been proposed, including hereditary gastric cancer, arsenic poisoning, and inappropriate medical treatment. We aimed to determine the etiology and pathogenesis of Napoleon's illness by a comparison of historical information with current clinicopathologic knowledge. Investigations: Evaluation of Napoleon's clinical history, original autopsy reports, and of historical documents. The clinicopathologic data from 135 gastric cancer patients were used for comparison with the data available on Napoleon. Diagnosis: At least T3N1M0 (stage IIIA) gastric cancer. Napoleon's tumor extended from the cardia to the pylorus (>10 cm) without infiltration of adjacent structures, which provides strong evidence for at least stage T3. The N1 stage was determined by the presence of several enlarged and hardened regional (perigastric) lymph nodes, and the M0 stage by the absence of distant metastasis. Analysis of the available historical documents indicates that Napoleon's main risk factor might have been Helicobacter pylori infection rather than a familial predisposition. Conclusions: Our analysis suggests that Napoleon's illness was a sporadic gastric carcinoma of advanced stage. Patients with such tumors have a notoriously poor prognosis.

Original languageEnglish (US)
Pages (from-to)52-57
Number of pages6
JournalNature Clinical Practice Gastroenterology and Hepatology
Volume4
Issue number1
DOIs
StatePublished - Jan 2007

Fingerprint

Stomach Neoplasms
Arsenic Poisoning
Cardia
Pylorus
Helicobacter Infections
Helicobacter pylori
Autopsy
Neoplasms
Stomach
Lymph Nodes
Neoplasm Metastasis
Carcinoma
Therapeutics

Keywords

  • Gastric cancer
  • Helicobacter pylori infection
  • Hereditary gastric cancer syndrome
  • Napoleon Bonaparte
  • TNM stage

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this

Napoleon Bonaparte's gastric cancer : A clinicopathologic approach to staging, pathogenesis, and etiology. / Lugli, Alessandro; Zlobec, Inti; Singer, Gad; Lugli, Andrea Kopp; Terracciano, Luigi M.; Genta, Robert M.

In: Nature Clinical Practice Gastroenterology and Hepatology, Vol. 4, No. 1, 01.2007, p. 52-57.

Research output: Contribution to journalArticle

Lugli, Alessandro ; Zlobec, Inti ; Singer, Gad ; Lugli, Andrea Kopp ; Terracciano, Luigi M. ; Genta, Robert M. / Napoleon Bonaparte's gastric cancer : A clinicopathologic approach to staging, pathogenesis, and etiology. In: Nature Clinical Practice Gastroenterology and Hepatology. 2007 ; Vol. 4, No. 1. pp. 52-57.
@article{aefcc74f70314d24a7b374595ff4028f,
title = "Napoleon Bonaparte's gastric cancer: A clinicopathologic approach to staging, pathogenesis, and etiology",
abstract = "Background: Numerous hypotheses on the cause of Napoleon Bonaparte's death have been proposed, including hereditary gastric cancer, arsenic poisoning, and inappropriate medical treatment. We aimed to determine the etiology and pathogenesis of Napoleon's illness by a comparison of historical information with current clinicopathologic knowledge. Investigations: Evaluation of Napoleon's clinical history, original autopsy reports, and of historical documents. The clinicopathologic data from 135 gastric cancer patients were used for comparison with the data available on Napoleon. Diagnosis: At least T3N1M0 (stage IIIA) gastric cancer. Napoleon's tumor extended from the cardia to the pylorus (>10 cm) without infiltration of adjacent structures, which provides strong evidence for at least stage T3. The N1 stage was determined by the presence of several enlarged and hardened regional (perigastric) lymph nodes, and the M0 stage by the absence of distant metastasis. Analysis of the available historical documents indicates that Napoleon's main risk factor might have been Helicobacter pylori infection rather than a familial predisposition. Conclusions: Our analysis suggests that Napoleon's illness was a sporadic gastric carcinoma of advanced stage. Patients with such tumors have a notoriously poor prognosis.",
keywords = "Gastric cancer, Helicobacter pylori infection, Hereditary gastric cancer syndrome, Napoleon Bonaparte, TNM stage",
author = "Alessandro Lugli and Inti Zlobec and Gad Singer and Lugli, {Andrea Kopp} and Terracciano, {Luigi M.} and Genta, {Robert M.}",
year = "2007",
month = "1",
doi = "10.1038/ncpgasthep0684",
language = "English (US)",
volume = "4",
pages = "52--57",
journal = "Nature Reviews Gastroenterology and Hepatology",
issn = "1759-5045",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Napoleon Bonaparte's gastric cancer

T2 - A clinicopathologic approach to staging, pathogenesis, and etiology

AU - Lugli, Alessandro

AU - Zlobec, Inti

AU - Singer, Gad

AU - Lugli, Andrea Kopp

AU - Terracciano, Luigi M.

AU - Genta, Robert M.

PY - 2007/1

Y1 - 2007/1

N2 - Background: Numerous hypotheses on the cause of Napoleon Bonaparte's death have been proposed, including hereditary gastric cancer, arsenic poisoning, and inappropriate medical treatment. We aimed to determine the etiology and pathogenesis of Napoleon's illness by a comparison of historical information with current clinicopathologic knowledge. Investigations: Evaluation of Napoleon's clinical history, original autopsy reports, and of historical documents. The clinicopathologic data from 135 gastric cancer patients were used for comparison with the data available on Napoleon. Diagnosis: At least T3N1M0 (stage IIIA) gastric cancer. Napoleon's tumor extended from the cardia to the pylorus (>10 cm) without infiltration of adjacent structures, which provides strong evidence for at least stage T3. The N1 stage was determined by the presence of several enlarged and hardened regional (perigastric) lymph nodes, and the M0 stage by the absence of distant metastasis. Analysis of the available historical documents indicates that Napoleon's main risk factor might have been Helicobacter pylori infection rather than a familial predisposition. Conclusions: Our analysis suggests that Napoleon's illness was a sporadic gastric carcinoma of advanced stage. Patients with such tumors have a notoriously poor prognosis.

AB - Background: Numerous hypotheses on the cause of Napoleon Bonaparte's death have been proposed, including hereditary gastric cancer, arsenic poisoning, and inappropriate medical treatment. We aimed to determine the etiology and pathogenesis of Napoleon's illness by a comparison of historical information with current clinicopathologic knowledge. Investigations: Evaluation of Napoleon's clinical history, original autopsy reports, and of historical documents. The clinicopathologic data from 135 gastric cancer patients were used for comparison with the data available on Napoleon. Diagnosis: At least T3N1M0 (stage IIIA) gastric cancer. Napoleon's tumor extended from the cardia to the pylorus (>10 cm) without infiltration of adjacent structures, which provides strong evidence for at least stage T3. The N1 stage was determined by the presence of several enlarged and hardened regional (perigastric) lymph nodes, and the M0 stage by the absence of distant metastasis. Analysis of the available historical documents indicates that Napoleon's main risk factor might have been Helicobacter pylori infection rather than a familial predisposition. Conclusions: Our analysis suggests that Napoleon's illness was a sporadic gastric carcinoma of advanced stage. Patients with such tumors have a notoriously poor prognosis.

KW - Gastric cancer

KW - Helicobacter pylori infection

KW - Hereditary gastric cancer syndrome

KW - Napoleon Bonaparte

KW - TNM stage

UR - http://www.scopus.com/inward/record.url?scp=33846049943&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846049943&partnerID=8YFLogxK

U2 - 10.1038/ncpgasthep0684

DO - 10.1038/ncpgasthep0684

M3 - Article

C2 - 17203089

AN - SCOPUS:33846049943

VL - 4

SP - 52

EP - 57

JO - Nature Reviews Gastroenterology and Hepatology

JF - Nature Reviews Gastroenterology and Hepatology

SN - 1759-5045

IS - 1

ER -